Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent tonic-clonic seizures and coma due to ingestion of Type I pyrethroids in a 19-month-old patient.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Air-oxygen helmet-delivered continuous positive airway pressure to manage respiratory failure due to bronchiolitis.

Acta paediatrica (Oslo, Norway : 1992)·2012
Same author

Non-invasive ventilation in pediatric intensive care.

Minerva pediatrica·2010
Same author

Can routine surveillance samples from tracheal aspirate predict bacterial flora in cases of ventilator-associated pneumonia?

Minerva anestesiologica·2009
Same author

Promoting epidural analgesia for labor: 2005-2007 diffusion in Lombardia, Italy.

Minerva anestesiologica·2008
Same author

Citrate anticoagulation during CVVH in high risk bleeding patients.

The International journal of artificial organs·2007

Related Experiment Video

Updated: May 16, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Cardiac arrest during sulprostone administration--a case report.

L Lampati1, L B Colantonio, E Calderini

  • 1Dipartimento di Anestesia, Terapia Intensiva e Terapia del Dolore, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. laura.lampati@fastwebnet.it

Acta Anaesthesiologica Scandinavica
|November 29, 2012
PubMed
Summary
This summary is machine-generated.

Sulprostone, a potent uterotonic drug, may cause cardiac arrest in postpartum women. This case highlights the risk of coronary spasm and bradycardia during its use for postpartum hemorrhage.

More Related Videos

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

Related Experiment Videos

Last Updated: May 16, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Pharmacology

Background:

  • Sulprostone is a synthetic prostaglandin analogue used for its strong uterotonic effects.
  • It has a reported low complication rate in extensive clinical use.
  • Postpartum hemorrhage remains a significant cause of maternal morbidity and mortality.

Observation:

  • A case of cardiac arrest occurred in a patient undergoing continuous intravenous sulprostone infusion.
  • The infusion was administered to manage atonic postpartum hemorrhage following a Cesarean section.
  • The patient required 25 minutes of cardiopulmonary resuscitation before spontaneous circulation returned.

Findings:

  • The event sequence, ICU investigations, and patient's cardiovascular risk factors suggest sulprostone-induced coronary spasm.
  • Bradycardia and subsequent asystole were observed, consistent with known adverse effects of prostaglandin analogues.
  • This case adds to the literature associating sulprostone with severe cardiovascular complications.

Implications:

  • Clinicians should be aware of the potential for serious cardiovascular adverse events with sulprostone, even with a low reported complication rate.
  • Careful patient selection and monitoring are crucial, especially in those with pre-existing cardiovascular risk factors.
  • Further research into the cardiovascular safety profile of sulprostone in high-risk populations is warranted.